Mark Sieczkarek

2018

In 2018, Mark Sieczkarek earned a total compensation of $345.1K as Former President and CEO at NovaBay Pharmaceuticals, a 78% decrease compared to previous year.

Compensation breakdown

Salary$330,000
Other$15,052
Total$345,052

Sieczkarek received $330K in salary, accounting for 96% of the total pay in 2018.

Sieczkarek also received $15.1K in other compensation.

Rankings

In 2018, Mark Sieczkarek's compensation ranked 12,883rd out of 14,244 executives tracked by ExecPay. In other words, Sieczkarek earned more than 9.6% of executives.

ClassificationRankingPercentile
All
12,883
out of 14,244
10th
Division
Manufacturing
5,216
out of 5,765
10th
Major group
Chemicals And Allied Products
1,963
out of 2,128
8th
Industry group
Drugs
1,683
out of 1,817
7th
Industry
Pharmaceutical Preparations
1,290
out of 1,391
7th
Source: SEC filing on April 19, 2019.

Sieczkarek's colleagues

We found three more compensation records of executives who worked with Mark Sieczkarek at NovaBay Pharmaceuticals in 2018.

2018

John McGovern

NovaBay Pharmaceuticals

Chief Executive Officer

2018

Justin Hall

NovaBay Pharmaceuticals

Chief Executive Officer

2018

Lewis Stuart

NovaBay Pharmaceuticals

Former Chief Commercial Officer

News

You may also like